megahitpoker| Dongfang Biotech (688298.SH): Net loss of 397 million yuan in 2023

Date: 5个月前 (04-29)View: 71Comments: 0

Gelonghui April 29 丨 Dongfang Biotech (688298megahitpoker.SH) releases 2023 annual reportmegahitpoker, achieve operating income 8megahitpoker.2 billion yuanmegahitpoker, a year-on-year decrease of 90.65%; net profit attributable to shareholders of listed companies-397 million yuan, net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses-431 million yuan, and basic earnings per share-1.97 yuan. In 2023, operating income decreased by 90.65% compared with the previous year. The main reason is that this year, the company mainly faced the basic elimination of COVID-19 testing product business, and the overall operating income dropped significantly year-on-year.

megahitpoker| Dongfang Biotech (688298.SH): Net loss of 397 million yuan in 2023

Tags:

Prev: mobileslotsfreespins| 8 million shares were traded at a premium in CICC Prologis REIT block transaction
Next: russianpoker| Accor Holdings (03313.HK) plans to conduct a share subdivision based on "1 to 20"

Related articlesNo more
︿